Some Supporting Information

November 25, 2011 at 9:14 am

[FONT=”Microsoft Sans Serif”]Jeanebell1 — Thank you for your comments. While Curcumin worked for my friend, it may not work for everyone. But, certainly its anti-imfammatory compounds are pretty well established. I’ll try show some documented studies that show its efficacy along with its low toxicity, even in very large doses.

This link shows some evidence regarding larger doses:

Below, I have found some links/articles that speak of Curcumin and its effects in terms of being an anti-imfammatory. The 1st article I site the link and paste the contents of the study. The rest of them I include only the link.

Food for thought.

Again, It is not I who reached longterm remission with Curcumin, it is a friend of mine who doesn’t post here. I did take it for a while at 10,000 mg per day. I personally suffered no ill effects.
J Altern Complement Med. 2003 Feb;9(1):161-8.
Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).
Chainani-Wu N.
Department of Stomatology, University of California, San Francisco, CA 94143-0658, USA. [email][/email]
Tumeric is a spice that comes from the root Curcuma longa, a member of the ginger family, Zingaberaceae. In Ayurveda (Indian traditional medicine), tumeric has been used for its medicinal properties for various indications and through different routes of administration, including topically, orally, and by inhalation. Curcuminoids are components of tumeric, which include mainly curcumin (diferuloyl methane), demethoxycurcumin, and bisdemethoxycurcmin.
The goal of this systematic review of the literature was to summarize the literature on the safety and anti-inflammatory activity of curcumin.
A search of the computerized database MEDLINE (1966 to January 2002), a manual search of bibliographies of papers identified through MEDLINE, and an Internet search using multiple search engines for references on this topic was conducted. The PDR for Herbal Medicines, and four textbooks on herbal medicine and their bibliographies were also searched.
A large number of studies on curcumin were identified. These included studies on the antioxidant, anti-inflammatory, antiviral, and antifungal properties of curcuminoids. Studies on the toxicity and anti-inflammatory properties of curcumin have included in vitro, animal, and human studies. A phase 1 human trial with 25 subjects using up to 8000 mg of curcumin per day for 3 months found no toxicity from curcumin. Five other human trials using 1125-2500 mg of curcumin per day have also found it to be safe. These human studies have found some evidence of anti-inflammatory activity of curcumin. The laboratory studies have identified a number of different molecules involved in inflammation that are inhibited by curcumin including phospholipase, lipooxygenase, cyclooxygenase 2, leukotrienes, thromboxane, prostaglandins, nitric oxide, collagenase, elastase, hyaluronidase, monocyte chemoattractant protein-1 (MCP-1), interferon-inducible protein, tumor necrosis factor (TNF), and interleukin-12 (IL-12).
Curcumin has been demonstrated to be safe in six human trials and has demonstrated anti-inflammatory activity. It may exert its anti-inflammatory activity by inhibition of a number of different molecules that play a role in inflammation.